Question : DBT supported the first CAR-T cell therapy has recently(June 2021) conducted at ACTREC, Tata Hospital in Mumbai. On which patients is CAR-T cell therapy effective?
a. Last stage blood cancer
b. Last stage breast cancer
c. Colon cancer
d. None of the above
Ans. a.
Related facts
- DBT supported the first CAR-T cell therapy has recently(June 2021) conducted at ACTREC, Tata Hospital in Mumbai. CAR-T cell therapy carried out for the first time in India.
- It is notable that this therapy is very effective on last stage blood cancer.
- Each patient’s CAR-T cell therapy costs 3-4 crore (INR). The challenge, therefore, is to develop this technology in a cost-effective manner and make it available for the patients.
- The central government’s National Biopharma Mission-BIRAC has approved 19.15 Cr crore to the team for conducting a first-in-human phase-1/2 clinical trial of the CAR-T cells.
- The first CAR-T cell treatment (a type of gene therapy) was performed in the Bone Marrow Transplant unit at Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Center in Mumbai on June 4, 2021, making it a momentous day for TMH, IIT Bombay, and cancer care in India.
DBT
- Under the Ministry of Science and Technology, the Department of Biotechnology (DBT) supports and accelerates the development of biotechnology in India, including its growth and use in agriculture, healthcare, animal sciences, environment, and industry.
By — Pankaj Pandey.